Northside Hospital is committed to expanding access to leading health care across Georgia. The health system announces the following network updates.
Patients have access to the same compassionate care and nationally recognized physicians they have come to know. Both locations will offer the same providers and services. With the new partnership, patients also have access to Georgia’s largest cancer network and the latest cancer research and treatments available.
Northside Hospital’s blood and marrow transplant program is a vital component of its comprehensive cancer care. The program offers patients a unique combination of academic-level expertise and the comfort of a community cancer program. Northside’s commitment to quality cancer care is evidenced by its impressive track record of success.
The program is the only blood and marrow transplant program in the United States to exceed allogeneic transplant survival rates for 12 consecutive years. Allogeneic transplant, also known as a stem cell transplant, is a procedure that replaces a patient’s bone marrow with healthy cells from a donor. This treatment is typically used to treat cancers such as leukemia, lymphoma, and multiple myeloma.
The outstanding results of Northside’s blood and marrow transplant program are attributed to the program’s world-class physicians and staff who use the latest technologies and innovative therapies to provide exceptional care. Patients who undergo treatment at Northside have access to some of the most experienced transplant teams in the country, ensuring that they receive the highest quality of care.
Northside’s commitment to quality cancer care is also demonstrated by the recognition it has received from the American College of Surgeons Commission on Cancer (CoC). The CoC has awarded Northside the Outstanding Achievement Award six times in a row. The award recognizes cancer programs that meet or exceed the CoC’s standards for patient-centered care, clinical outcomes, and research.
In addition to its outstanding transplant program, Northside Hospital has been selected by the National Cancer Institute (NCI) to lead a statewide research network. This network provides patients in their own community with access to state-of-the-art clinical research. Patients who participate in clinical trials have the opportunity to receive cutting-edge treatments and therapies that are not yet available to the general public.
Northside’s blood and marrow transplant program is more than just a medical treatment. The program’s staff understands that cancer can be emotionally and physically draining for patients and their families. That’s why they provide support services to help patients cope with the challenges of cancer. These services include emotional support groups, counseling, and education on managing side effects.
The program’s holistic approach to cancer care has earned it high marks from patients. In fact, 95% of cancer patients recommend Northside to family and friends. Patients appreciate the program’s commitment to providing quality care and support throughout their cancer journey.
In conclusion, Northside Hospital’s blood and marrow transplant program is a leader in providing exceptional cancer care. The program’s world-class physicians and staff use the latest technologies and innovative therapies to achieve outstanding results. Patients who undergo treatment at Northside receive not only medical care but also emotional and physical support. The program’s commitment to quality cancer care has earned it the trust and confidence of patients and their families.